Mutations in BRAF are one of the most frequent oncogenic molecular events in cancer and in particular have been implicated in malignant melanoma, non-small cell lung cancer, papillary thyroid cancer, and glioma. Here, BRAF is linked to non-small cell lung carcinoma.